Genomics of alternative splicing: Evolution, development and pathophysiology

Eric R. Gamazon*, Barbara Elaine Stranger

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

62 Scopus citations

Abstract

Alternative splicing is a major cellular mechanism in metazoans for generating proteomic diversity. A large proportion of protein-coding genes in multicellular organisms undergo alternative splicing, and in humans, it has been estimated that nearly 90 % of protein-coding genes - much larger than expected - are subject to alternative splicing. Genomic analyses of alternative splicing have illuminated its universal role in shaping the evolution of genomes, in the control of developmental processes, and in the dynamic regulation of the transcriptome to influence phenotype. Disruption of the splicing machinery has been found to drive pathophysiology, and indeed reprogramming of aberrant splicing can provide novel approaches to the development of molecular therapy. This review focuses on the recent progress in our understanding of alternative splicing brought about by the unprecedented explosive growth of genomic data and highlights the relevance of human splicing variation on disease and therapy.

Original languageEnglish (US)
Pages (from-to)679-687
Number of pages9
JournalHuman Genetics
Volume133
Issue number6
DOIs
StatePublished - Jan 1 2014

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Fingerprint

Dive into the research topics of 'Genomics of alternative splicing: Evolution, development and pathophysiology'. Together they form a unique fingerprint.

Cite this